Recent Updates

Modified on: 
Sep 5, 2018

Authors: Sandra Ramirez-Arcos, PhD, Mariam Taha, PhD, Yuntong Kou, MSc, and Mindy Goldman, MD, FRCPC
Online publication date: February 2017

Transfusion
Modified on: 
Sep 5, 2018

In August 2017, Canadian Blood Services changed its platelet product testing procedure to improve the detection of bacterial contamination. This change enhanced the safety of Canadian Blood Services platelet products and provided the opportunity to improve inventory management by extending the platelet shelf life from five to seven days.

Transfusion
Modified on: 
Sep 5, 2018

Transfusion-related acute lung injury (TRALI) is a rare but serious syndrome characterized by sudden acute respiratory distress following transfusion. It is defined as new, acute lung injury (ALI) during or within six hours after blood product administration in the absence of temporally-associated risk factors for ALI. 

Transfusion
Modified on: 
Sep 5, 2018

Authors: Robert Skeate, MD, MSc and Mindy Goldman, MD, FRCPC
Online publication date: July 2014

Key points

Transfusion
Modified on: 
Sep 5, 2018

Author: Mindy Goldman, MD, FRCPC
Online publication date: March 2012, updated July 2018

Transfusion
Modified on: 
Sep 5, 2018

Current recommendations of the NAC indicate that the provision of CMV-seronegative and leukoreduced blood products is potentially required only in the setting of intrauterine transfusion. In October 2017, Canadian Blood Services will stop the testing donor blood for anti-CMV antibodies except for a small inventory of blood components tested for the sole purpose of intrauterine transfusion.

Transfusion
Modified on: 
Sep 5, 2018

Canadian guidelines for the uniform labelling of blood and blood components using ISBT 128

Transfusion
Modified on: 
Aug 27, 2018

This chapter describes when and how to use the plasma protein product albumin and introduces therapeutic alternatives to albumin.

Transfusion
Modified on: 
Aug 27, 2018

The approach to transfusion in emergent situations varies dramatically depending on the clinical scenario. The primary guiding determinant is the clinician’s assessment of the rapidity of bleeding, the severity of hemorrhage or amount of blood lost, and the clinical stability of the patient. Using the severely injured trauma patient as a case study, this chapter will discuss the principles of massive hemorrhage and resuscitation, with the inclusion of special situations such as obstetrical hemorrhage, where data are available.

Transfusion

Pages